Intake reports
What was taken, when, and how much.
Last 30 days. Aggregate session reporting only — no patient-level identity is shown.
Tracked sessions
1,097
↑ 5% vs previous periodContributing patients
391
Anonymous referencesAvg. reported effectiveness
4.0/ 5
1,057 rated sessionsSessions with amount recorded
1,037
Unrecorded amounts are excluded from amount viewsVolume over time
Weekly tracked sessions in the selected window
16 Jul023 Jul030 Jul006 Aug6813 Aug25420 Aug25027 Aug26503 Sept260
Sessions by medicine
Share of tracked sessions
Tinroof44% · 481
Colour of Space31% · 339
Apple Fritter25% · 277
Based on 1,097 sessions
Sessions by time of day
Recorded intake time
Morning33% · 367
Afternoon30% · 331
Evening30% · 334
Night6% · 65
Based on 1,097 sessions
Amount distribution
Grouped amounts in grams
0.10–0.14 g24% · 253
0.15–0.19 g26% · 270
0.20–0.29 g23% · 239
0.30 g and over19% · 197
Under 0.10 g8% · 78
1,037 sessions with a recorded amount
Duration distribution
Recorded duration bands
< 1 hour7% · 74
1–2 hours28% · 290
2–4 hours40% · 416
4–6 hours19% · 201
6+ hours6% · 68
1,049 sessions with a recorded duration
Amount views describe reported outcome by amount group. They are research intelligence and are not dosing guidance.